• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于2型糖尿病所致脑能量代谢变化的阿尔茨海默病病理学与治疗方法

Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes.

作者信息

Yanai Hidekatsu, Adachi Hiroki, Hakoshima Mariko, Katsuyama Hisayuki

机构信息

Department of Diabetes, Endocrinology and Metabolism, National Center for Global Health and Medicine Kohnodai Hospital, 1-7-1 Kohnodai, Ichikawa 272-8516, Chiba, Japan.

出版信息

Molecules. 2024 Dec 16;29(24):5936. doi: 10.3390/molecules29245936.

DOI:10.3390/molecules29245936
PMID:39770025
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11677283/
Abstract

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with cognitive dysfunction, memory decline, and behavioral disturbance, and it is pathologically characterized by the accumulation of amyloid plaques and neurofibrillary tangles in the brain. Although various hypotheses have been proposed to explain the pathogenesis of AD, including the amyloid beta hypothesis, oxidative stress hypothesis, and abnormal phosphorylation of tau proteins, the exact pathogenic mechanisms underlying AD remain largely undefined. Furthermore, effective curative treatments are very limited. Epidemiologic studies provide convincing evidence for a significant association between type 2 diabetes and AD. Here, we showed energy metabolism using glucose, lactate, ketone bodies, and lipids as energy substrates in a normal brain, and changes in such energy metabolism due to type 2 diabetes. We also showed the influences of such altered energy metabolism due to type 2 diabetes on the pathology of AD. Furthermore, we comprehensively searched for risk factors related with type 2 diabetes for AD and showed possible therapeutic interventions based on considering risk factors and altered brain energy metabolism due to type 2 diabetes for the development of AD.

摘要

阿尔茨海默病(AD)是一种进行性神经退行性疾病,伴有认知功能障碍、记忆力减退和行为紊乱,其病理特征是大脑中淀粉样斑块和神经原纤维缠结的积累。尽管已经提出了各种假说来解释AD的发病机制,包括β-淀粉样蛋白假说、氧化应激假说和tau蛋白异常磷酸化,但AD的确切致病机制在很大程度上仍不明确。此外,有效的治疗方法非常有限。流行病学研究为2型糖尿病与AD之间的显著关联提供了令人信服的证据。在这里,我们展示了正常大脑中以葡萄糖、乳酸、酮体和脂质作为能量底物的能量代谢,以及2型糖尿病导致的这种能量代谢变化。我们还展示了2型糖尿病导致的这种能量代谢改变对AD病理的影响。此外,我们全面搜索了与2型糖尿病相关的AD危险因素,并基于考虑危险因素和2型糖尿病导致的大脑能量代谢改变,展示了针对AD发展的可能治疗干预措施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/999f281bfb36/molecules-29-05936-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/95664b406dfc/molecules-29-05936-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/9bf19a9a518a/molecules-29-05936-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/b1adcd1b85a4/molecules-29-05936-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/999f281bfb36/molecules-29-05936-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/95664b406dfc/molecules-29-05936-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/9bf19a9a518a/molecules-29-05936-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/b1adcd1b85a4/molecules-29-05936-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/892f/11677283/999f281bfb36/molecules-29-05936-g004.jpg

相似文献

1
Pathology and Treatments of Alzheimer's Disease Based on Considering Changes in Brain Energy Metabolism Due to Type 2 Diabetes.基于2型糖尿病所致脑能量代谢变化的阿尔茨海默病病理学与治疗方法
Molecules. 2024 Dec 16;29(24):5936. doi: 10.3390/molecules29245936.
2
Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.从紊乱的大脑葡萄糖代谢解码阿尔茨海默病:对诊断和治疗策略的影响。
Prog Neurobiol. 2013 Sep;108:21-43. doi: 10.1016/j.pneurobio.2013.06.004. Epub 2013 Jul 11.
3
Diabetes Mellitus Induces Alzheimer's Disease Pathology: Histopathological Evidence from Animal Models.糖尿病诱发阿尔茨海默病病理:来自动物模型的组织病理学证据。
Int J Mol Sci. 2016 Apr 5;17(4):503. doi: 10.3390/ijms17040503.
4
Liraglutide Protects Against Brain Amyloid-β Accumulation in Female Mice with Early Alzheimer's Disease-Like Pathology by Partially Rescuing Oxidative/Nitrosative Stress and Inflammation.利拉鲁肽通过部分缓解氧化/亚硝化应激和炎症,对具有早期阿尔茨海默病样病理的雌性小鼠脑内淀粉样β蛋白积累具有保护作用。
Int J Mol Sci. 2020 Mar 4;21(5):1746. doi: 10.3390/ijms21051746.
5
Review: Relationship of type 2 diabetes to human brain pathology.综述:2 型糖尿病与人类大脑病理的关系。
Neuropathol Appl Neurobiol. 2018 Jun;44(4):347-362. doi: 10.1111/nan.12476. Epub 2018 Mar 4.
6
Insulin signaling: An opportunistic target to minify the risk of Alzheimer's disease.胰岛素信号传导:降低阿尔茨海默病风险的一个潜在靶点。
Psychoneuroendocrinology. 2017 Sep;83:159-171. doi: 10.1016/j.psyneuen.2017.05.004. Epub 2017 May 30.
7
Insulin Resistance at the Crossroad of Alzheimer Disease Pathology: A Review.阿尔茨海默病病理交汇点的胰岛素抵抗:综述。
Front Endocrinol (Lausanne). 2020 Nov 5;11:560375. doi: 10.3389/fendo.2020.560375. eCollection 2020.
8
A unifying hypothesis of Alzheimer's disease. IV. Causation and sequence of events.阿尔茨海默病的统一假说。IV. 病因及事件顺序。
Rev Neurosci. 2000;11 Spec No:213-328. doi: 10.1515/revneuro.2000.11.s1.213.
9
Depletion of Caveolin-1 in Type 2 Diabetes Model Induces Alzheimer's Disease Pathology Precursors.Caveolin-1 耗竭在 2 型糖尿病模型中诱导阿尔茨海默病病理前体的形成。
J Neurosci. 2019 Oct 23;39(43):8576-8583. doi: 10.1523/JNEUROSCI.0730-19.2019. Epub 2019 Sep 16.
10
GLP-1 receptor stimulation reduces amyloid-beta peptide accumulation and cytotoxicity in cellular and animal models of Alzheimer's disease.GLP-1 受体刺激可减少阿尔茨海默病细胞和动物模型中的淀粉样β肽积累和细胞毒性。
J Alzheimers Dis. 2010;19(4):1205-19. doi: 10.3233/JAD-2010-1314.

引用本文的文献

1
Burden of risk factors attributable to Alzheimer's disease and other dementia and its relationship with the Socio-Demographic index in Asia.亚洲地区可归因于阿尔茨海默病和其他痴呆症的风险因素负担及其与社会人口指数的关系。
BMC Neurol. 2025 Jun 9;25(1):247. doi: 10.1186/s12883-025-04265-7.

本文引用的文献

1
Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease.胰高血糖素样肽-1 受体激动剂在阿尔茨海默病和帕金森病中的作用。
J Biomed Sci. 2024 Nov 5;31(1):102. doi: 10.1186/s12929-024-01090-x.
2
Overview of oxidative stress and inflammation in diabetes.糖尿病中氧化应激和炎症的概述。
J Diabetes. 2024 Oct;16(10):e70014. doi: 10.1111/1753-0407.70014.
3
Type 2 diabetes mellitus and neurodegenerative disorders: The mitochondrial connection.2 型糖尿病与神经退行性疾病:线粒体的联系。
Pharmacol Res. 2024 Nov;209:107439. doi: 10.1016/j.phrs.2024.107439. Epub 2024 Sep 30.
4
The role and mechanism of dapagliflozin in Alzheimer disease: A review.达格列净在阿尔茨海默病中的作用和机制:综述。
Medicine (Baltimore). 2024 Sep 27;103(39):e39687. doi: 10.1097/MD.0000000000039687.
5
New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer's disease.脂质代谢的新见解:治疗阿尔茨海默病的潜在治疗靶点。
Front Neurosci. 2024 Sep 11;18:1430465. doi: 10.3389/fnins.2024.1430465. eCollection 2024.
6
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes.钠-葡萄糖协同转运蛋白 2 抑制剂在 2 型糖尿病患者中的使用与痴呆和帕金森病风险。
Neurology. 2024 Oct 22;103(8):e209805. doi: 10.1212/WNL.0000000000209805. Epub 2024 Sep 18.
7
From BBB to PPP: Bioenergetic requirements and challenges for oligodendrocytes in health and disease.从血脑屏障到神经血管单元:健康与疾病状态下少突胶质细胞的生物能量需求及挑战
J Neurochem. 2025 Jan;169(1):e16219. doi: 10.1111/jnc.16219. Epub 2024 Sep 10.
8
The emerging role of exercise in Alzheimer's disease: Focus on mitochondrial function.运动在阿尔茨海默病中的新作用:聚焦于线粒体功能。
Ageing Res Rev. 2024 Nov;101:102486. doi: 10.1016/j.arr.2024.102486. Epub 2024 Sep 6.
9
Microglial activation and polarization in type 2 diabetes-related cognitive impairment: A focused review of pathogenesis.2 型糖尿病相关认知障碍中小胶质细胞的激活和极化:发病机制的重点综述。
Neurosci Biobehav Rev. 2024 Oct;165:105848. doi: 10.1016/j.neubiorev.2024.105848. Epub 2024 Aug 13.
10
Assessment of sodium-glucose cotransporter 2 inhibitors (SGLT2i) and other antidiabetic agents in Alzheimer's disease: A population-based study.评估钠-葡萄糖共转运蛋白 2 抑制剂(SGLT2i)和其他抗糖尿病药物在阿尔茨海默病中的作用:一项基于人群的研究。
Pharmacol Res. 2024 Aug;206:107295. doi: 10.1016/j.phrs.2024.107295. Epub 2024 Jul 4.